“…Duplication of 22q11.2 was also identified by a team of researchers at the Albert Einstein College of Medicine (Edelmann et al, 1999). Many cases of 22q11.2 duplication were shown to exhibit epilepsy, ID, ADHD, and ASD (Ensenauer et al, 2003; Hassed et al, 2004; Portnoï et al, 2005, 2009; Yobb et al, 2005; de La Rochebrochard et al, 2006; Alberti et al, 2007; Engels et al, 2007; Mukaddes and Herguner, 2007; Torres-Juan et al, 2007; Descartes et al, 2008; Ramelli et al, 2008; Wentzel et al, 2008; Yu et al, 2008; Lo-Castro et al, 2009; Soysal et al, 2011; Wenger et al, 2016) at rates higher than those of noncarriers (Hoeffding et al, 2017; Olsen et al, 2018). Schizophrenia samples have shown lower rates of 22q11.2 duplication compared with controls; therefore, this variant is considered to be a protective factor (Rees et al, 2014a).…”